over a month ago at Macroaxis 
By Achuva Shats
Inspite very unsteady forward-looking indicators, S A P displayed solid returns over the last few months and may actually be approaching a breakup point. Macroaxis considers S A P very steady given 1 month investment horizon. SAP SE owns Efficiency Ratio (i.e. Sharpe Ratio) of 0.0829 which indicates the company had 0.0829% of return per unit of standard deviation over the last 1 month. Our approach into measuring volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for SAP SE which you can use to evaluate future volatility of the entity. Please operate S A P Risk Adjusted Performance of 0.0514, Market Risk Adjusted Performance of 0.121 and Downside Deviation of 1.48 to confirm if our risk estimates are consistent with your expectations.
 S A P  fundamentals ideas   s a p technology software - application
  over a month ago at Macroaxis 
By Vlad Skutelnik
In spite of rather unsteady fundamental drivers, CME exhibited solid returns over the last few months and may actually be approaching a breakup point. We found thirty-eight available fundamental indicators for CME Group which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all CME Group fundamentals including its Current Valuation, Price to Book, Cash and Equivalents, as well as the relationship between Shares Owned by Institutions and Gross Profit . Given that CME Group has Price to Earning of 34.39X, we suggest you validate CME Group prevailing market performance to make sure the company can sustain itself in the future. Use CME to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of CME to be traded at $209.57 in 30 days.
 CME  fundamentals ideas   cme financial services financial exchanges trading
  over a month ago at Macroaxis 
By Vlad Skutelnik
In spite of rather sound fundamental drivers, ABIOMED is not utilizing all of its potentials. The continuing stock price tumult, may contribute to shorter-term losses for the shareholders. ABIOMED shows prevailing Real Value of $198.73 per share. The current price of the entity is $270.39. At this time the entity appears to be overvalued. Macroaxis approximates value of ABIOMED from evaluating the entity fundamentals such as Profit Margin of 33.66%, Current Valuation of 11.26B and Shares Outstanding of 45.12M as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some future date assets prices and their ongoing real values will blend.
 ABIOMED  fundamentals ideas   abiomed healthcare medical devices medical equipment
  over a month ago at Macroaxis 
By Achuva Shats
In this story I am going to address all ongoing Encore Capital shareholders. I will look into why despite ongoing dip, the longer-term fundamental drivers of the firm are still sound. In spite of rather sluggish fundamental drivers, Encore Capital exhibited solid returns over the last few months and may actually be approaching a breakup point. Macroaxis considers Encore Capital somewhat reliable given 1 month investment horizon. Encore Capital Group secures Sharpe Ratio (or Efficiency) of 0.2034 which denotes the organization had 0.2034% of return per unit of standard deviation over the last 1 month. Our philosophy in predicting volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. By reviewing Encore Capital Group technical indicators you can presently evaluate if the expected return of 0.7633% is justified by implied risk. Please utilize Encore Capital Group Downside Deviation of 2.46, Mean Deviation of 2.31 and Semi Deviation of 1.93 to check if our risk estimates are consistent with your expectations.
 Encore Capital  fundamentals ideas   encore capital financial services asset management banking
  over a month ago at Macroaxis 
By Achuva Shats
This thesis is geared towards all PICO Holdings partners and investors who considers an exit from the corporation. I will inspect the possibilities of making PICO Holdings into a steady grower in June inspite the current mess. Allthough quite unsteady forward indicators, PICO Holdings may actually be approaching a critical reversion point that can send shares even higher in June 2019. We found thirty-four available financial indicators for PICO Holdings which can be compared to its peers in the sector. To make sure the equity is not overpriced, please check all PICO Holdings fundamentals including its Cash per Share, Market Capitalization and the relationship between Revenue and Cash Flow from Operations . Given that PICO Holdings has Number of Shares Shorted of 435.31K, we recommend you check out PICO Holdings latest market performance to make sure the company can sustain itself for few more years. Use PICO Holdings to protect your portfolios against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of PICO Holdings to be traded at $10.75 in 30 days.
 PICO Holdings  fundamentals ideas   pico holdings real estate real estate - general
  over a month ago at Macroaxis 
By Vlad Skutelnik
This feature is directed to investors considering to exit their positions in Commerce Bancshares. I will examine why in spite of prevalent disturbance, the overall long-run investment outlook of the entity is still stable. Despite nearly weak fundamental indicators, Commerce Bancshares may actually be approaching a critical reversion point that can send shares even higher in June 2019. We found thirty-two available fundamental indicators for Commerce Bancshares which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Commerce Bancshares fundamentals including its Total Debt, Beta and the relationship between Gross Profit and Short Ratio . Given that Commerce Bancshares has Number of Shares Shorted of 3.39M, we suggest you validate Commerce Bancshares prevailing market performance to make sure the company can sustain itself down the road. Use Commerce Bancshares to protect your portfolios against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of Commerce Bancshares to be traded at $57.04 in 30 days.
 Commerce Bancshares  fundamentals ideas   commerce bancshares financial services banks - regional - us banking
  over a month ago at Macroaxis 
By Vlad Skutelnik
In spite of rather weak fundamental drivers, Steris Plc exhibited solid returns over the last few months and may actually be approaching a breakup point. We found thirty-seven available drivers for Steris Plc which can be compared to its competition. To make sure the equity is not overpriced, please validate all Steris Plc fundamentals including its Debt to Equity, Total Asset and the relationship between EBITDA and Earnings Per Share . Given that Steris Plc has Price to Book of 3.58X, we advise you double-check Steris Plc current market performance to make sure the company can sustain itself down the road. Use Steris Plc to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Steris Plc to be traded at $142.19 in 30 days.
 Steris Plc  fundamentals ideas   steris plc healthcare medical instruments & supplies
  over a month ago at Macroaxis 
By Vlad Skutelnik
Despite somewhat fragile basic indicators, SVB Financial may actually be approaching a critical reversion point that can send shares even higher in June 2019. We found thirty-one available financial indicators for SVB Financial which can be compared to its peers in the sector. To make sure the equity is not overpriced, please validate all SVB Financial Group fundamentals including its Net Income, Earnings Per Share and the relationship between Price to Book and Debt to Equity . Given that SVB Financial Group has Shares Owned by Institutions of 93.22% , we advise you double-check SVB Financial latest market performance to make sure the company can sustain itself next year. Use SVB Financial to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of SVB Financial to be traded at $247.06 in 30 days.
 SVB Financial  fundamentals ideas   svb financial financial services banks - regional - us
  over a month ago at Macroaxis 
By Vlad Skutelnik
Regardless of fairly consistent technical and fundamental indicators, Trustmark is not utilizing all of its potentials. The prevalent stock price confusion, may contribute to short-lasting losses for the traders. We found thirty-three available drivers for Trustmark Corporation which can be compared to its competition. To make sure the equity is not overpriced, please validate all Trustmark fundamentals including its Book Value Per Share, and the relationship between Net Income and Number of Employees . Given that Trustmark has Number of Shares Shorted of 5.26M, we advise you double-check Trustmark Corporation current market performance to make sure the company can sustain itself down the road. Use Trustmark to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of Trustmark to be traded at $36.61 in 30 days.
 Trustmark  fundamentals ideas   trustmark financial services banks - regional - us
  over a month ago at Macroaxis 
By Vlad Skutelnik
This article is aimed at all current or potential E I investors. I will look into why albeit cyclical E I disturbance, the long term basic indicators of the company are still strong. Despite somewhat strong basic indicators, E I is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short term losses for the investors. We found thirty available fundamental indicators for E I du Pont de Nemours and Company which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all E I du fundamentals including its Price to Sales, Net Income and the relationship between Price to Earning and Gross Profit . Given that E I du has Price to Earning of 36.11X, we urge you verify E I du Pont de Nemours and Company prevailing market performance to make sure the company can sustain itself this quarter and beyond. Use E I to protect your portfolios against small markets fluctuations. The stock experiences normal downward trend and little activity. Check odds of E I to be traded at $103.35 in 30 days.
 E I  fundamentals ideas   e i basic materials chemicals

Share Stories

Syndicate Stories to major social sites

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Search macroaxis.com